Company intelligence / Profile preview

AncoCare Pharmatech

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

AncoCare Pharmatech is a clinical-stage biotechnology company based in Beijing, China, specializing in the development of innovative cancer immunotherapies. The company leverages a proprietary mRNA technology platform to design and manufacture personalized neoantigen-based vaccines and other nucleic acid therapeutics. Their lead pipeline programs focus on treating advanced solid tumors by utilizing mRNA-LNP delivery systems to stimulate robust T-cell responses against patient-specific mutations. AncoCare aims to bridge the gap between bioinformatics-driven drug design and advanced manufacturing to deliver highly individualized medicine.

Therapeutic areas: Oncology
Modalities: mRNA-based drugsLipid nanoparticle delivery therapyVaccineImmunotherapy
Industry: Biotech

Beyond the preview

Go deeper on AncoCare Pharmatech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AncoCare Pharmatech.

Explore the full profile